Prof Erik Stroes is a vascular internist with a longstanding track of research in the field of lipidology, inflammation and atherosclerosis. Current research foci encompass the use of CT-angiography as a guide to tailored treatment regimens, pathophysiology of Lp(a) in atherogenesis and anti-inflammatory strategies in high cardiovascular risk patients.
He is leading the lipid-clinic at AmsterdamUMC in the Netherlands. He has co-authored more than 540 peer-reviewed articles in the field of atherogenesis, (familial) hypercholesterolemia and cardiovascular treatment. He is Chair of the Dutch foundation aiming to optimize screening for familial hypercholesterolemia (LEEFH) and involved in several landmark trials in the cardiovascular arena.

Contributions

Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry.Epidemiology of FHPublicationPaediatric Lipid Working GroupMy patient has high Lp(a). What do I do?Lp(a) Awareness DayCME Session: High Lp(a): why does it matter?93rd EAS Congress 2025Multi-omics in CV-medicine92nd EAS Congress 2024Plenary 03"Fire and Forget" Time to say Goodbye?92nd EAS Congress 2024CME session 2LCN Lp(a) webinar series #3: Recommendations for Lp(a) screeningLp(a) Awareness DayWebinars on-demandReimagining population health-the time is now - Discussion and Q&A90th EAS Congress 2022Reimagining population health-the time is nowWho will benefit most from PCSK9i?89th EAS Congress 2021(Anti PCSK9ReviewCholesterolTreatmentHypolipidemic drugs)Is there a role for Advanced Atherosclerosis Imaging in targeted cardiovascular therapy?EAS 2017 AC on Precision Medicine in ANew lipid drugs - Is LDL done, ready for new targets?87th EAS Congress 2019Lipids, inflammation and CV risk86th EAS Congress 2018